FDA Approves Cobenfy as Novel Schizophrenia Treatment with First-in-Decades Mechanism
The U.S. Food and Drug Administration (FDA) has granted official approval to Cobenfy (KarXT, xanomeline...
Hunan Province Includes Fertility Treatments in Medical Insurance Coverage from October 2024
The Hunan Healthcare Security Administration has issued a notification to include specific assisted reproductive medical...
Shanghai Junshi Biosciences Inks Licensing Deal for IAMA-001 Nasal Spray with Nanjing JSIAMA
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180), a biopharmaceutical company based in China,...
China’s Pharmaceutical Industry Sees Mixed Results in H1 2024, CAPEM Data Reveals
The China Association of Pharmaceutical Enterprises Management (CAPEM) has released a comprehensive set of data...
Shanghai Medical Procurement Platform Sets Price Cap for Non-Locally Supplied Drugs
Shanghai’s Sunshine Medical Procurement All-In-One (SMPA) has issued a notification concerning the online procurement prices...
Pfizer Partners with Shanghai Pharmaceutical for Long-Term Vaccine Collaboration in China
Pfizer Inc. (NSE: PFIZER, NYSE: PFE, ETR: PFE), a leading pharmaceutical company in the U.S.,...
FDA Panel Weighs in on Narrowing Use of PD-1 Inhibitors in Stomach and Esophageal Cancers
The U.S. FDA’s Oncologic Drugs Advisory Committee (ODAC) convened on September 26 to scrutinize the...
2seventy bio and BMS Discontinue Phase III Trial for Multiple Myeloma Therapy Abecma
2seventy bio Inc. (NASDAQ: TSVT), a U.S.-based biotechnology company partnered with Bristol-Myers Squibb (BMS, NYSE:...
Zelgen Biopharmaceuticals Receives NMPA Approval for ZG005 Clinical Trial in Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266), a biopharmaceutical company based in China, has announced...
Johnson & Johnson Reportedly Winding Down Cardiovascular and Metabolic Pharma Unit
Johnson & Johnson (J&J; NYSE: JNJ), a healthcare giant in the U.S., is reportedly winding...
Jiangsu Hengrui Pharmaceuticals Gets NMPA Green Light for Generic Vizamyl Clinical Trial
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...
Sansure Biotech’s HPV Detection Kit Receives NMPA Approval for Comprehensive Screening
Sansure Biotech Inc., a molecular diagnostics specialist based in China and listed on the Shanghai...
ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the...
Sino Biopharmaceutical Receives NMPA Approval for Rivastigmine Patch for Mild-to-Moderate Alzheimer’s
Sino Biopharmaceutical Ltd (HKG: 1177), a leading biopharmaceutical company based in China, has announced that...
Belief BioMed Partners with Bayer’s AskBio to Explore New Gene Therapies
Belief BioMed Inc. (BBM), a Chinese biopharmaceutical company specializing in gene therapy, has announced a...
Shanghai Fosun Pharmaceutical Partners with State-owned Firms to Boost ASEAN Drug Trade
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company in...
Beijing Authorities Launch Plan to Streamline Temporary Import of Urgently Needed Medical Drugs and Devices
In a joint effort to streamline access to critical medical resources, the Beijing Municipal Medical...
Beijing Expands Medical Insurance Coverage to Include Anti-Aquaporin Antibody Testing and Advanced Heart Procedures
The Beijing Municipal Medical Insurance Bureau and the Beijing Municipal Human Resources and Social Security...
Innovent Biologics Submits Market Approval Filing for Picankibart in Plaque Psoriasis to China’s CDE
Innovent Biologics Inc., (HKG: 1801), a leading biopharmaceutical company based in China, has reportedly submitted...
Shanghai Haihe Pharmaceutical’s Oral Paclitaxel RMX3001 Wins NMPA Nod for Advanced Gastric Cancer
Shanghai Haihe Pharmaceutical Co., Ltd from China and its South Korean partner Daehwa Pharmaceutical have...